Streptococcus rapid test - Import export

Screen Test Streptococcus A is a rapid test for self-diagnostic use for the qualitative detection of group A streptococcus antigen from pharyngeal swab specimens to aid in the early diagnosis of group A Streptococcus infection. The package contains 2 Strep A tests. Screen Check Test Streptococcus A is an in vitro diagnostic medical device CE 0123. Read the warnings and operating instructions carefully. Authorization of 7/04/2021.

Screen Test Streptococcus A is a rapid test for self-diagnostic use for the qualitative detection of group A streptococcus antigen from pharyngeal swab specimens to aid in the early diagnosis of group A Streptococcus infection. Screen Check Test Streptococcus A is an in vitro diagnostic medical device CE 0123. Read the warnings and operating instructions carefully. Authorization of 7/04/2021. Benefits Streptococcus A detection Rapid result for streptococcal A antigen

Streptococcus A Rapid Test – Product code: SC-0715-20 Immunoassay well on single-phase membrane for the rapid and qualitative determination of group A streptococcal antigens directly from the throat swab, also present in the package the positive and negative control. The Strep A rapid test is a rapid immunochromatographic test for the qualitative detection of Strep A antigens in throat swab specimens to aid in the diagnosis of Group A Streptococcal infections. The Strep A rapid test is a rapid test that qualitatively detects the presence of Strep A antigens in throat swab specimens, giving results within 5 minutes. The test uses Lancefield Group A Strep A whole cell specific antibodies to selectively detect Strep A antigens in a throat swab specimen.

The SARS-CoV-2 (COVID-19) Antigen Rapid Test (Saliva) is a single-use test intended to detect in human saliva the novel coronavirus SARS-CoV-2 that causes COVID-19. This test is designed for home use with saliva samples collected independently from symptomatic individuals suspected of being infected with SARS-CoV-2. With the rapid SARS-CoV-2 (COVID-19) antigen test (Saliva), only a preliminary result is obtained; final confirmation should be based on the results of clinical diagnosis. Result in 15 minutes. Screen Check Test Covid-19 Saliva is an in vitro diagnostic medical device CE 1434. Read the warnings and instructions for use carefully.

The Clostridium difficile Toxin A + Toxin B combination rapid test (Feces) is a rapid chromatographic immunoassay for the qualitative detection of Toxin A and Toxin B Clostridium difficile antigens in human stool samples. The Clostridium difficile Toxin A + Toxin B Combination Rapid Test detects two distinct antigens in stool samples for C. difficile, viz., Toxin A and Toxin B on two different test strips in the same device, thus simultaneously detects two specific Clostridium antigens hard. Clostridium difficile is an anaerobic bacterium that acts as an opportunistic pathogen: it grows in the intestine when the normal flora is altered by antibiotic therapy. Toxigenic strains of Clostridium difficile cause infections from simple diarrhea to pseudomembranous colitis, which can even cause death. The disease is caused by two toxins produced by the toxigenic strains of C. difficile:

Covid-19 Antigen Rapid test for proffessional use

rqmicro AG develops and markets high-quality reagents and instruments for microbial tests in water and food. Water labs benefit from newly available kits to detect Legionella in combination with a flow cytometer in 1-2 hours instead of 12-14 days.

Easy handling thanks to minimally invasive sampling as a nasal swab (2.5 cm depth) Also very good for use with small children, students, handicapped people, professional sports activities and in companies This test is Made in Germany and approved for use by laypersons Reliable with 100% sensitivity and 98% specificity

BfArM listed: AT563/21 Evaluated by the Paul Ehrlich Institute Reliable with 96% sensitivity and 99% specificity Use only by medically trained personnel

With the self/rapid test you get a high-quality corona antigen self-test, which is used for the qualitative detection of SARS-CoV-2 nucleocapsid antigens in the front nasal cavity in a short time. It is based on the lateral flow immunoassay method, which uses antibodies to detect specific antigens in the sample swab.

Clungene's rapid antigen test is on the BfArM's list and is therefore reimbursable according to the "Ordinance on the entitlement to testing in relation to a direct pathogen detection of the coronavirus SARS-CoV-2". Available at short notice, for med. Qualified Personnel: Clungene COVID-19 Rapid Antigen Test Clungene COVID-19 antigen rapid test (pack of 25 test cassettes) Shipping directly from Germany! Product details Test for the qualitative detection of the SARS-CoV-2 antigen Tool for diagnosing an acute SARS-CoV-2 infection On the list of the BfArM (Federal Institute for Drugs and Medical Devices) Sampling with a nasopharynx swab The test result is available after 15 minutes Sensitivity: 98.50%, specificity: 100% Store at room temperature (between 4 ° and 30 ° C) Please note that this rapid test may only be used by medical specialists! Excluded from the right of return Packaging unit: 25 test cassettes Contents per box